Free Trial

Ultragenyx Pharmaceutical (RARE) SEC Filings & 10K Form

$55.24
-1.21 (-2.14%)
(As of 09/6/2024 ET)

Recent Ultragenyx Pharmaceutical SEC Filings

DateFilerForm TypeView
09/05/2024
10:50 AM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
10:53 AM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:40 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
1:48 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:28 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
1:07 PM
Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:22 PM
Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:23 PM
Ray Amrit (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:24 PM
NARACHI MICHAEL (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:25 PM
Ultragenyx Pharmaceutical (Issuer)
WELCH DANIEL G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:26 PM
Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:29 PM
Dunsire Deborah (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:22 PM
SULIMAN SHEHNAAZ (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
5:31 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
4:11 PM
Ultragenyx Pharmaceutical (Filer)
Form 424B5
06/12/2024
6:47 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
4:10 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2024
4:20 PM
Ultragenyx Pharmaceutical (Filer)
Form 424B5
06/10/2024
6:58 PM
Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
4:20 PM
Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/03/2024
2:23 PM
Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
3:35 PM
Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
5:06 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
7:07 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
12:41 PM
Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
5:39 PM
Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
11:54 AM
Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:13 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:15 PM
Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:17 PM
Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:19 PM
Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:22 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:23 PM
Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:06 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:08 PM
Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:10 PM
Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:46 AM
RTW INVESTMENTS, LP (Filed by)
Ultragenyx Pharmaceutical (Subject)
Form SC 13G/A
02/13/2024
2:41 PM
SANDS CAPITAL MANAGEMENT, LLC (Filed by)
Ultragenyx Pharmaceutical (Subject)
Form SC 13G
02/08/2024
2:49 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
9:18 AM
Ultragenyx Pharmaceutical (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/29/2024
2:26 PM
BlackRock Inc. (Filed by)
Ultragenyx Pharmaceutical (Subject)
Form SC 13G/A
"Doomsday indicator” flashing for the first time since the Great Depression... (Ad)

It's been a bloodbath in the markets. The seven most valuable US tech companies lost a combined $1 trillion - in a single day. And things could get a lot worse...

Click here to discover how Wall Street insiders are quietly preparing for a market crash >>>
01/08/2024
5:03 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:17 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2023
4:22 PM
Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
4:14 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
3:47 PM
Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2023
5:31 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2023
5:31 AM
Ultragenyx Pharmaceutical (Filer)
Form 424B5
10/19/2023
3:45 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2023
6:49 PM
Ultragenyx Pharmaceutical (Subject)
Form FWP
10/17/2023
3:13 PM
Ultragenyx Pharmaceutical (Filer)
Form 424B5
10/16/2023
7:05 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2023
11:48 AM
Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/10/2023
11:50 AM
Horn Howard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
1:15 PM
Crombez Eric (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
1:16 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
12:33 PM
Ultragenyx Pharmaceutical (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
09/11/2023
12:52 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2023
7:00 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/07/2023
4:01 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:RARE) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners